Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Pharma industry loses on Medicare price ...

Drug companies have formed a new group to present lawmakers with research on what the industry sees as the negative impacts ...

The drug industry’s top lobbying group is appealing its latest loss in its challenge to Medicare’s Drug Price Negotiation ...

The Inflation Reduction Act (IRA) authorized the federal government to force prescription drug manufacturers to "negotiate" drug prices for ...

Our Drug Pricing and Market Access team tracks recent developments in healthcare reform, the Medicaid Drug Rebate Program, the 340B Program, ...

A voluntary rebate pilot for the 340B drug discount program is drawing attention as a potential way to address concerns over ...

Despite breakthrough treatments and medical advances, heart disease - the nation’s top killer - has claimed even more lives ...

The Health Resources and Services Administration (HRSA) issued a notice announcing the application process for the 340B rebate model pilot program ...

The U.S. healthcare system is fragmented and expensive, costing approximately 18% of GDP. Medicaid acts as a safety net for ...

Meridian Funds, managed by ArrowMark Partners, released its “Meridian Growth Fund” second-quarter 2025 investor letter. A copy of the letter can be downloaded here. U.S. equity markets made a ...

New York hospitals that get discounted drugs through a controversial federal program are gearing up for a new pilot that they ...